Date: December 10-13, 2001
Location: San Antonio, Texas, USA
Symposium Web Page: www.sabcs.org
Sponsors: Cancer Therapy & Research Center, and UTHSCSA
Who Should Attend: Academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as other appropriate health care professionals.
Objectives: To provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.
Registration Info: Online registration is available.
Dec 13, 2013 - Anastrozole reduces the risk of breast cancer by about half with few side effects in postmenopausal women at high risk of developing breast cancer, according to a study presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 10 to 14 in San Antonio. The research was simultaneously published online Dec. 12 in The Lancet.